Xinan Wang

1.3k total citations
35 papers, 384 citations indexed

About

Xinan Wang is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Xinan Wang has authored 35 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Hematology and 7 papers in Cancer Research. Recurrent topics in Xinan Wang's work include Hematopoietic Stem Cell Transplantation (6 papers), Histone Deacetylase Inhibitors Research (4 papers) and Acute Myeloid Leukemia Research (4 papers). Xinan Wang is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Histone Deacetylase Inhibitors Research (4 papers) and Acute Myeloid Leukemia Research (4 papers). Xinan Wang collaborates with scholars based in China, Japan and United States. Xinan Wang's co-authors include Hideki Muramatsu, Fu Wang, Jiawang Ding, Xiaohong Tong, Si Chen, Haifeng Zheng, Yoshiyuki Takahashi, Atsushi Narita, Jie Tian and Beilei Zhang and has published in prestigious journals such as Blood, PLoS ONE and Analytical Chemistry.

In The Last Decade

Xinan Wang

34 papers receiving 381 citations

Peers

Xinan Wang
Shinya Osone Japan
Mohd Minhajuddin United States
Teodora Karan-Djurašević Serbia
Mariko Takenokuchi Japan
Robert M. Sutphin United States
Mark W. Hazel United States
Sı́lvia Casas Spain
Enrica Antonia Martino Italy
Shinya Osone Japan
Xinan Wang
Citations per year, relative to Xinan Wang Xinan Wang (= 1×) peers Shinya Osone

Countries citing papers authored by Xinan Wang

Since Specialization
Citations

This map shows the geographic impact of Xinan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinan Wang more than expected).

Fields of papers citing papers by Xinan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinan Wang. The network helps show where Xinan Wang may publish in the future.

Co-authorship network of co-authors of Xinan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xinan Wang. A scholar is included among the top collaborators of Xinan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinan Wang. Xinan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xinan, Chengdang Xu, Xi Chen, et al.. (2024). PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling. Cell Death and Disease. 15(2). 128–128. 5 indexed citations
2.
Zhou, Juan, Qinghua Wang, Yaru Zhu, et al.. (2024). Study on the Predictive Value of Renal Resistive Index Combined with β2-Microglobulin in Patients with Urosepsis Complicated with Acute Kidney Injury. Journal of Inflammation Research. Volume 17. 9583–9599. 3 indexed citations
3.
Chen, Xi, Xinan Wang, Haopeng Li, et al.. (2024). Glycolysis related lncRNA SNHG3 / miR-139-5p / PKM2 axis promotes castration-resistant prostate cancer (CRPC) development and enzalutamide resistance. International Journal of Biological Macromolecules. 260(Pt 2). 129635–129635. 13 indexed citations
4.
Xu, Chengdang, Xinan Wang, Yiran Tao, et al.. (2023). Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression. Cell Death Discovery. 9(1). 392–392. 4 indexed citations
5.
Wang, Xinan, Xi Chen, Chengdang Xu, Weidong Zhou, & Denglong Wu. (2023). Identification of cuproptosis-related genes for predicting the development of prostate cancer. Open Medicine. 18(1). 20230717–20230717. 3 indexed citations
6.
7.
Chen, Xi, et al.. (2022). CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer. European journal of medical research. 27(1). 105–105. 8 indexed citations
8.
Wang, Man, et al.. (2021). Analysis of cardiovascular disease factors on SARS-CoV-2 infection severity. Medicina Clínica. 159(4). 171–176. 1 indexed citations
9.
Zhang, Beilei, Xinan Wang, Haifeng Zheng, et al.. (2019). p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma. Cancer Letters. 459. 50–58. 62 indexed citations
10.
Zheng, Haifeng, et al.. (2019). Intron Retained Bioluminescence Reporter for Real-Time Imaging of Pre-mRNA Splicing in Living Subjects. Analytical Chemistry. 91(19). 12392–12398. 4 indexed citations
11.
Xiao, Ying, et al.. (2018). Characterization of a novel selective factor Xa inhibitor, DJT06001, which reduces thrombus formation with low risk of bleeding. European Journal of Pharmacology. 825. 85–91. 3 indexed citations
12.
Chen, Zhihao, et al.. (2018). Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention. Archives of Medical Science. 15(6). 1375–1380. 11 indexed citations
13.
Sekiya, Yuko, Yusuke Okuno, Hideki Muramatsu, et al.. (2016). JAK2, MPL, and CALR mutations in children with essential thrombocythemia. International Journal of Hematology. 104(2). 266–267. 8 indexed citations
14.
Sakaguchi, Hirotoshi, Hideki Muramatsu, Yusuke Okuno, et al.. (2015). Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia. PLoS ONE. 10(12). e0145394–e0145394. 25 indexed citations
15.
Imamura, Toshihiko, Hideki Muramatsu, Xinan Wang, et al.. (2015). Serial investigation of PTPN11 mutation in nonhematopoietic tissues in a patient with juvenile myelomonocytic leukemia who was treated with unrelated cord blood transplantation. International Journal of Hematology. 102(6). 719–722. 2 indexed citations
16.
Hyakuna, Nobuyuki, Hideki Muramatsu, Takeshi Higa, et al.. (2014). Germline Mutation of CBL Is Associated With Moyamoya Disease in a Child With Juvenile Myelomonocytic Leukemia and Noonan Syndrome‐Like Disorder. Pediatric Blood & Cancer. 62(3). 542–544. 29 indexed citations
17.
18.
Sakata, Naoki, Hideki Muramatsu, Hirotoshi Sakaguchi, et al.. (2014). Clinical course of juvenile myelomonocytic leukemia in the blast crisis phase treated by acute myeloid leukemia-oriented chemotherapy and allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 100(5). 502–506. 1 indexed citations
19.
Sakaguchi, Hiroshi, Nobuhiko Nishio, Asahito Hama, et al.. (2014). Peripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemia. Haematologica. 99(8). 1312–1316. 33 indexed citations
20.
Wang, Xinan, et al.. (2014). Histone deacetylases and atherosclerosis. Atherosclerosis. 240(2). 355–366. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinya Osone Breakdown of academic impact, for papers by Mohd Minhajuddin Breakdown of academic impact, for papers by Teodora Karan-Djurašević Breakdown of academic impact, for papers by Mariko Takenokuchi Breakdown of academic impact, for papers by Robert M. Sutphin Breakdown of academic impact, for papers by Mark W. Hazel Breakdown of academic impact, for papers by Sı́lvia Casas Breakdown of academic impact, for papers by Enrica Antonia Martino
Rankless by CCL
2026